Richard Vincent

Mr. Richard G.
Vincent, CPA, is an Independent Director at Forte Biosciences, Inc., a Chief Financial Officer & Treasurer at Oncternal Therapeutics, Inc., a Chief Financial Advisor at GenrAb, Inc., a Chief Financial Advisor at Medcura, Inc. and a Chief Financial Officer & Secretary at Oncternal Oncology, Inc. He is on the Board of Directors at Forte Biosciences, Inc. Mr. Vincent was previously employed as a Chief Financial Officer by DioGenix, Inc., a Chief Financial Officer by Avalyn Pharma, Inc., a Chief Financial Officer, Secretary & EVP by Sorrento Therapeutics, Inc., a Chief Financial Officer by Elevation Pharmaceuticals, Inc., a Chief Financial Officer by Meritage Pharma, Inc., a Chief Financial Officer & Vice President by Verus Pharmaceuticals, Inc., a Chief Financial Officer & Vice President by Women First HealthCare, Inc., a Senior Manager by D&T Partners LLP, a Chief Financial Officer by Blue Octy LLC, a Chief Financial Officer by Elan Pharmaceuticals LLC, and a Chief Financial Officer & Treasurer by VelosBio, Inc. He received his undergraduate degree from San Diego State University.